Clinical Trials for Advanced Hepatocellular Carcinoma (HCC)

Find clinical trials for advanced hepatocellular carcinoma (hcc). Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)

NCT ID: NCT07039201

This clinical trial is studying a new treatment called CG-102-12C for people with advanced liver cancer (hepatocellular carcinoma) that tests positive for a specific marker called GPC3. This study ...

Not yet recruiting

Phase: NA Type: interventional Locations: Hangzhou, Zhejiang, China

Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma

NCT ID: NCT06995105

This clinical trial is exploring a new treatment for advanced liver cancer, specifically a type called hepatocellular carcinoma (HCC). The researchers want to see if a personalized therapy that use...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

NCT ID: NCT06902389

This clinical trial is exploring a new treatment for patients with advanced liver cancer, known as hepatocellular carcinoma (HCC), who have not responded to other therapies. The treatment involves ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Yangpu District, China

A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion

NCT ID: NCT06828380

This clinical trial is designed to compare two treatment approaches for patients with advanced liver cancer, specifically a type called hepatocellular carcinoma (HCC) that has spread to nearby bloo...

Recruiting

Phase: PHASE2 Type: interventional Locations: Goyang, , Korea, Republic Of

Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma

NCT ID: NCT06749678

This clinical trial is studying how a program called "prehabilitation" can help patients with advanced liver cancer (specifically unresectable hepatocellular carcinoma) who are getting ready for a ...

Not yet recruiting

Phase: NA Type: interventional Locations: Guangzhou, Guangdong, China

HAI or IV of Adebrelimab, Combined with Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

NCT ID: NCT06737913

This clinical trial is investigating a new treatment approach for patients with advanced hepatocellular carcinoma (HCC), which is a type of liver cancer that cannot be surgically removed. The study...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Phase 2 Study of WGI-0301 for Advanced HCC

NCT ID: NCT06309485

This clinical trial is investigating a treatment called WGI-0301 in combination with another medication named Sorafenib for adults with advanced liver cancer, specifically a type called hepatocellu...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions